BM-162353

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameBM-162353
Drug Alias NameBM-162266BM-162353BM-162056BM-162287BM-162354 +[6
ClassificationSmall molecules
Mechanisms of ActionPhospholipases A2 inhibitorsCytokine synthesis inhibitors
TargetsPhospholipases A2
Therapy Area/IndicationsInflammationArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRoche Holding Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoehringer Mannheim Gmbh
Active IndicationsN/A
Inactive IndicationsInflammationArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A